Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis
Annals of hematology(2018)
摘要
Current prognostication in myelofibrosis (MF) is based on clinicopathological features and mutations in a limited number of driver genes. The impact of other genetic mutations remains unclear. We evaluated for mutations in a myeloid panel of 54 genes using next-generation sequencing. Multivariate Cox regression analysis was used to determine prognostic factors for overall survival (OS) and leukaemia-free survival (LFS), based on mutations of these genes and relevant clinical and haematological features. One hundred and one patients (primary MF, N = 70; secondary MF, N = 31) with a median follow-up of 49 (1–256) months were studied. For the entire cohort, inferior OS was associated with male gender ( P = 0.04), age > 65 years ( P = 0.04), haemoglobin < 10 g/dL ( P = 0.001), CUX1 mutation ( P = 0.003) and TP53 mutation ( P = 0.049); and inferior LFS was associated with male gender ( P = 0.03), haemoglobin < 10 g/dL ( P = 0.04) and SRSF2 mutations ( P = 0.008). In primary MF, inferior OS was associated with male gender ( P = 0.03), haemoglobin < 10 g/dL ( P = 0.002), platelet count < 100 × 10 9 /L ( P = 0.02), TET2 mutation ( P = 0.01) and CUX1 mutation ( P = 0.01); and inferior LFS was associated with haemoglobin < 10 g/dL ( P = 0.02), platelet count < 100 × 10 9 /L ( P = 0.02), TET2 mutations ( P = 0.01) and CUX1 mutations ( P = 0.04). These results showed that clinical and haematological features and genetic mutations should be considered in MF prognostication.
更多查看译文
关键词
Myelofibrosis,Primary,Secondary,Next-generation sequencing,Prognosis
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要